TreeWAS – Variant ID: rs7964120

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
F31 Bipolar affective disorder	0.000	0.254	0.746
F31.0 Bipolar affective disorder, current episode hypomanic	0.000	0.265	0.735
F31.1 Bipolar affective disorder, current episode manic without psychotic symptoms	0.000	0.268	0.732
F31.6 Bipolar affective disorder, current episode mixed	0.000	0.276	0.724
F31.4 Bipolar affective disorder, current episode severe depression without psychotic symptoms	0.000	0.318	0.682
F31.2 Bipolar affective disorder, current episode manic with psychotic symptoms	0.000	0.384	0.616
F31.3 Bipolar affective disorder, current episode mild or moderate depression	0.000	0.413	0.587
F31.7 Bipolar affective disorder, currently in remission	0.000	0.423	0.577
F31.5 Bipolar affective disorder, current episode severe depression with psychotic symptoms	0.000	0.444	0.555
F31.8 Other bipolar affective disorders	0.000	0.465	0.535
F31.9 Bipolar affective disorder, unspecified	0.000	0.514	0.486
H40.0 Glaucoma suspect	0.000	0.976	0.024
F30-F39 Mood [affective] disorders	0.000	0.976	0.024
I46.9 Cardiac arrest, unspecified	0.018	0.982	0.000
F38 Other mood [affective] disorders	0.000	0.983	0.017
K70.1 Alcoholic hepatitis	0.016	0.984	0.000
F34 Persistent mood [affective] disorders	0.000	0.985	0.015
I46 Cardiac arrest	0.015	0.985	0.000
F39 Unspecified mood [affective] disorder	0.000	0.985	0.015
I46.0 Cardiac arrest with successful resuscitation	0.015	0.985	0.000
K70.9 Alcoholic liver disease, unspecified	0.015	0.985	0.000
K70 Alcoholic liver disease	0.015	0.985	0.000
K70.0 Alcoholic fatty liver	0.013	0.987	0.000
I46.1 Sudden cardiac death, so described	0.013	0.987	0.000
M23.24 Derangement of meniscus due to old tear or injury (Lateral collateral ligament or Anterior horn of lateral meniscus)	0.013	0.987	0.000
K70.2 Alcoholic fibrosis and sclerosis of liver	0.013	0.987	0.000
F38.8 Other specified mood [affective] disorders	0.000	0.987	0.012
F38.1 Other recurrent mood [affective] disorders	0.000	0.987	0.012
F38.0 Other single mood [affective] disorders	0.000	0.987	0.012
F30 Manic episode	0.000	0.988	0.012
S22.20 Fracture of sternum (closed)	0.000	0.988	0.012
F34.9 Persistent mood [affective] disorder, unspecified	0.000	0.989	0.011
F34.8 Other persistent mood [affective] disorders	0.000	0.989	0.011
F34.0 Cyclothymia	0.000	0.989	0.011
K70.3 Alcoholic cirrhosis of liver	0.010	0.990	0.000
F34.1 Dysthymia	0.000	0.991	0.009
K70.4 Alcoholic hepatic failure	0.009	0.991	0.000
F30.0 Hypomania	0.000	0.991	0.009
F30.8 Other manic episodes	0.000	0.991	0.009
F30.1 Mania without psychotic symptoms	0.000	0.991	0.008
S22.2 Fracture of sternum	0.000	0.992	0.008
O03.4 Incomplete, without complication	0.000	0.992	0.008
F30.2 Mania with psychotic symptoms	0.000	0.992	0.007
F33 Recurrent depressive disorder	0.000	0.993	0.007
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.007	0.993	0.000
F33.0 Recurrent depressive disorder, current episode mild	0.000	0.993	0.007
F30.9 Manic episode, unspecified	0.000	0.993	0.006
H35.3 Degeneration of macula and posterior pole	0.000	0.994	0.006
S22.21 Fracture of sternum (open)	0.000	0.994	0.006
Z95.9 Presence of cardiac and vascular implant and graft, unspecified	0.006	0.994	0.000
S22.30 Fracture of rib (closed)	0.000	0.994	0.006
S22.3 Fracture of rib	0.000	0.994	0.006
S22 Fracture of rib(s), sternum and thoracic spine	0.000	0.994	0.006
F33.4 Recurrent depressive disorder, currently in remission	0.000	0.995	0.005
O03 Spontaneous abortion	0.000	0.995	0.005
S22.1 Multiple fractures of thoracic spine	0.000	0.995	0.005
O03.1 Incomplete, complicated by delayed or excessive haemorrhage	0.000	0.995	0.005
F33.2 Recurrent depressive disorder, current episode severe without psychotic symptoms	0.000	0.995	0.005
S22.5 Flail chest	0.000	0.995	0.005
S22.10 Multiple fractures of thoracic spine (closed)	0.000	0.995	0.005
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.005	0.995	0.000
S22.31 Fracture of rib (open)	0.000	0.996	0.004
S22.9 Fracture of bony thorax, part unspecified	0.000	0.996	0.004
S22.8 Fracture of other parts of bony thorax	0.000	0.996	0.004
F33.8 Other recurrent depressive disorders	0.000	0.996	0.004
Y52.3 Coronary vasodilators, not elsewhere classified	0.004	0.996	0.000
K75.8 Other specified inflammatory liver diseases	0.004	0.996	0.000
B95.0 Streptococcus, group A, as the cause of diseases classified to other chapters	0.004	0.996	0.000
O03.7 Complete or unspecified, complicated by embolism	0.000	0.996	0.004
O03.6 Complete or unspecified, complicated by delayed or excessive haemorrhage	0.000	0.996	0.004
O03.5 Complete or unspecified, complicated by genital tract and pelvic infection	0.000	0.996	0.004
O03.2 Incomplete, complicated by embolism	0.000	0.996	0.004
O03.0 Incomplete, complicated by genital tract and pelvic infection	0.000	0.996	0.004
S22.50 Flail chest (closed)	0.000	0.996	0.004
F52.2 Failure of genital response	0.004	0.996	0.000
O03.3 Incomplete, with other and unspecified complications	0.000	0.996	0.004
F33.1 Recurrent depressive disorder, current episode moderate	0.000	0.996	0.004
S22.11 Multiple fractures of thoracic spine (open)	0.000	0.996	0.004
E10.3 With ophthalmic complications	0.004	0.996	0.000
Y56.3 Emollients, demulcents and protectants	0.004	0.996	0.000
H40 Glaucoma	0.000	0.996	0.004
K55.9 Vascular disorder of intestine, unspecified	0.004	0.996	0.000
O03.9 Complete or unspecified, without complication	0.000	0.996	0.004
F33.3 Recurrent depressive disorder, current episode severe with psychotic symptoms	0.000	0.996	0.003
H40.1 Primary open-angle glaucoma	0.000	0.996	0.004
S22.0 Fracture of thoracic vertebra	0.000	0.996	0.004
S22.51 Flail chest (open)	0.000	0.996	0.003
Y56.9 Topical agent, unspecified	0.003	0.996	0.000
Y56.8 Other topical agents	0.003	0.996	0.000
Y56.7 Dental drugs, topically applied	0.003	0.996	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.003	0.996	0.000
Y56.5 Ophthalmological drugs and preparations	0.003	0.996	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.003	0.996	0.000
Y56.2 Local astringents and local detergents	0.003	0.996	0.000
Y56.1 Antipruritics	0.003	0.996	0.000
O03.8 Complete or unspecified, with other and unspecified complications	0.000	0.997	0.003
C65 Malignant neoplasm of renal pelvis	0.003	0.997	0.000
Q50.4 Embryonic cyst of Fallopian tube	0.003	0.997	0.000
Q54 Hypospadias	0.003	0.997	0.000
Q50 Congenital malformations of ovaries, Fallopian tubes and broad ligaments	0.003	0.997	0.000
S22.81 Fracture of other parts of bony thorax (open)	0.000	0.997	0.003
S22.80 Fracture of other parts of bony thorax (closed)	0.000	0.997	0.003
S22.91 Fracture of bony thorax, part unspecified (open)	0.000	0.997	0.003
S22.90 Fracture of bony thorax, part unspecified (closed)	0.000	0.997	0.003
Y52 Agents primarily affecting the cardiovascular system	0.003	0.997	0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.003	0.997	0.000
Q54.9 Hypospadias, unspecified	0.003	0.997	0.000
Q50-Q56 Congenital malformations of genital organs	0.003	0.997	0.000
H35.4 Peripheral retinal degeneration	0.000	0.997	0.003
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.003	0.997	0.000
Q54.8 Other hypospadias	0.003	0.997	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.003	0.997	0.000
K72.9 Hepatic failure, unspecified	0.003	0.997	0.000
F33.9 Recurrent depressive disorder, unspecified	0.000	0.997	0.003
H40.6 Glaucoma secondary to drugs	0.000	0.997	0.003
K59.8 Other specified functional intestinal disorders	0.000	0.997	0.003
Q54.1 Hypospadias, penile	0.003	0.997	0.000
Q50.5 Embryonic cyst of broad ligament	0.003	0.997	0.000
Q52 Other congenital malformations of female genitalia	0.003	0.997	0.000
F32 Depressive episode	0.000	0.997	0.003
H35 Other retinal disorders	0.000	0.997	0.003
O20.9 Haemorrhage in early pregnancy, unspecified	0.000	0.997	0.003
S22.01 Fracture of thoracic vertebra (open)	0.000	0.997	0.003
Q53 Undescended testicle	0.003	0.997	0.000
O04.4 Incomplete, without complication	0.000	0.997	0.003
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.003	0.997	0.000
Q51.2 Other doubling of uterus	0.003	0.997	0.000
Q51 Congenital malformations of uterus and cervix	0.003	0.997	0.000
Q54.4 Congenital chordee	0.003	0.997	0.000
Q54.3 Hypospadias, perineal	0.003	0.997	0.000
Q54.2 Hypospadias, penoscrotal	0.003	0.997	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.003	0.997	0.000
S22.4 Multiple fractures of ribs	0.000	0.997	0.003
F32.0 Mild depressive episode	0.000	0.997	0.003
Q50.6 Other congenital malformatons of Fallopian tube and broad ligament	0.003	0.997	0.000
Q50.3 Other congenital malformations of ovary	0.003	0.997	0.000
Q50.2 Congenital torsion of ovary	0.003	0.997	0.000
Q50.1 Developmental ovarian cyst	0.003	0.997	0.000
Q50.0 Congenital absence of ovary	0.003	0.997	0.000
Q54.0 Hypospadias, balanic	0.003	0.997	0.000
Q52.8 Other specified congenital malformations of female genitalia	0.003	0.997	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.997	0.003
K72 Hepatic failure, not elsewhere classified	0.003	0.997	0.000
H35.0 Background retinopathy and retinal vascular changes	0.000	0.997	0.003
Y52.1 Calcium-channel blockers	0.003	0.997	0.000
I34.0 Mitral (valve) insufficiency	0.000	0.997	0.003
Y52.8 Antivaricose drugs, including sclerosing agents	0.003	0.997	0.000
Y52.7 Peripheral vasodilators	0.003	0.997	0.000
K70-K77 Diseases of liver	0.003	0.997	0.000
H40.8 Other glaucoma	0.000	0.997	0.003
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.002	0.997	0.000
Q56 Indeterminate sex and pseudohermaphroditism	0.002	0.997	0.000
Q53.1 Undescended testicle, unilateral	0.002	0.997	0.000
O20.8 Other haemorrhage in early pregnancy	0.000	0.997	0.003
Q55 Other congenital malformations of male genital organs	0.002	0.997	0.000
Q52.1 Doubling of vagina	0.002	0.997	0.000
H40.4 Glaucoma secondary to eye inflammation	0.000	0.997	0.002
Q52.4 Other congenital malformations of vagina	0.002	0.997	0.000
H40.9 Glaucoma, unspecified	0.000	0.998	0.002
B97.7 Papillomavirus as the cause of diseases classified to other chapters	0.000	0.998	0.002
Y46.7 Anti-Parkinsonism drugs	0.002	0.998	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.002	0.998	0.000
Q51.4 Unicornate uterus	0.002	0.998	0.000
M19.96 Arthrosis, unspecified-Lower leg	0.002	0.998	0.000
Q52.9 Congenital malformation of female genitalia, unspecified	0.002	0.998	0.000
Q52.7 Other congenital malformations of vulva	0.002	0.998	0.000
Q52.6 Congenital malformation of clitoris	0.002	0.998	0.000
Q52.3 Imperforate hymen	0.002	0.998	0.000
Q52.2 Congenital rectovaginal fistula	0.002	0.998	0.000
Q52.0 Congenital absence of vagina	0.002	0.998	0.000
H35.1 Retinopathy of prematurity	0.000	0.998	0.002
Q53.2 Undescended testicle, bilateral	0.002	0.998	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.002	0.998	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.002	0.998	0.000
H40.3 Glaucoma secondary to eye trauma	0.000	0.998	0.002
Q53.9 Undescended testicle, unspecified	0.002	0.998	0.000
Q53.0 Ectopic testis	0.002	0.998	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.002	0.998	0.000
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)	0.000	0.998	0.002
G55.3 Nerve root and plexus compressions in other dorsopathies	0.002	0.998	0.000
Q51.9 Congenital malformation of uterus and cervix, unspecified	0.002	0.998	0.000
Q51.7 Congenital fistulae between uterus and digestive and urinary tracts	0.002	0.998	0.000
Q51.6 Embryonic cyst of cervix	0.002	0.998	0.000
Q51.5 Agenesis and aplasia of cervix	0.002	0.998	0.000
Q51.1 Doubling of uterus with doubling of cervix and vagina	0.002	0.998	0.000
Q51.0 Agenesis and aplasia of uterus	0.002	0.998	0.000
Y52.4 Angiotensin-converting-enzyme inhibitors	0.002	0.998	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.002	0.998	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.002	0.998	0.000
Y41.4 Anthelminthics	0.002	0.998	0.000
Y41.3 Other antiprotozoal drugs	0.002	0.998	0.000
Y41.1 Antimycobacterial drugs	0.002	0.998	0.000
R40.0 Somnolence	0.002	0.998	0.000
S22.41 Multiple fractures of ribs (open)	0.000	0.998	0.002
Q55.0 Absence and aplasia of testis	0.002	0.998	0.000
Y55.4 Expectorants	0.002	0.998	0.000
M81.90 Osteoporosis, unspecified (Multiple sites)	0.000	0.998	0.002
C80.0 Malignant neoplasm, primary site unknown, so stated	0.002	0.998	0.000
H35.5 Hereditary retinal dystrophy	0.000	0.998	0.002
K72.1 Chronic hepatic failure	0.002	0.998	0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.002	0.998	0.000
D07.5 Prostate	0.000	0.998	0.002
Q55.2 Other congenital malformations of testis and scrotum	0.002	0.998	0.000
R93.2 Abnormal findings on diagnostic imaging of liver and biliary tract	0.000	0.998	0.002
Q51.8 Other congenital malformations of uterus and cervix	0.002	0.998	0.000
K77 Liver disorders in diseases classified elsewhere	0.002	0.998	0.000
E14.3 With ophthalmic complications	0.002	0.998	0.000
Q56.4 Indeterminate sex, unspecified	0.002	0.998	0.000
Q56.3 Pseudohermaphroditism, unspecified	0.002	0.998	0.000
Q56.2 Female pseudohermaphroditism, not elsewhere classified	0.002	0.998	0.000
Q56.1 Male pseudohermaphroditism, not elsewhere classified	0.002	0.998	0.000
Q56.0 Hermaphroditism, not elsewhere classified	0.002	0.998	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.002	0.998	0.000
S22.00 Fracture of thoracic vertebra (closed)	0.000	0.998	0.002
H35.7 Separation of retinal layers	0.000	0.998	0.002
H40.2 Primary angle-closure glaucoma	0.000	0.998	0.002
Q52.5 Fusion of labia	0.002	0.998	0.000
K75 Other inflammatory liver diseases	0.002	0.998	0.000
Q55.9 Congenital malformation of male genital organ, unspecified	0.002	0.998	0.000
Q55.8 Other specified congenital malformations of male genital organs	0.002	0.998	0.000
Q55.5 Congenital absence and aplasia of penis	0.002	0.998	0.000
Q55.4 Other congenital malformations of vas deferens, epididymis, seminal vesicles and prostate	0.002	0.998	0.000
Q55.3 Atresia of vas deferens	0.002	0.998	0.000
Q55.1 Hypoplasia of testis and scrotum	0.002	0.998	0.000
G58.9 Mononeuropathy, unspecified	0.002	0.998	0.000
O00-O08 Pregnancy with abortive outcome	0.000	0.998	0.002
H92.0 Otalgia	0.002	0.998	0.000
Y41.0 Sulphonamides	0.002	0.998	0.000
Y46.4 Iminostilbenes	0.002	0.998	0.000
O20 Haemorrhage in early pregnancy	0.000	0.998	0.002
H35.8 Other specified retinal disorders	0.000	0.998	0.002
Q61.2 Polycystic kidney, adult type	0.000	0.998	0.002
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.002	0.998	0.000
Y55.5 Anticommon cold drugs	0.002	0.998	0.000
Y55.3 Antitussives	0.002	0.998	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.002	0.998	0.000
Y55.0 Oxytocic drugs	0.002	0.998	0.000
F52 Sexual dysfunction, not caused by organic disorder or disease	0.002	0.998	0.000
Y48 Anaesthetics and therapeutic gases	0.002	0.998	0.000
H35.9 Retinal disorder, unspecified	0.000	0.998	0.002
K71 Toxic liver disease	0.002	0.998	0.000
E04.1 Non-toxic single thyroid nodule	0.002	0.998	0.000
Y48.2 Other and unspecified general anaesthetics	0.002	0.998	0.000
O04 Medical abortion	0.000	0.998	0.002
Y42.7 Androgens and anabolic congeners	0.002	0.998	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.002	0.998	0.000
F32.2 Severe depressive episode without psychotic symptoms	0.000	0.998	0.002
H35.2 Other proliferative retinopathy	0.000	0.998	0.002
Y46.8 Antispasticity drugs	0.002	0.998	0.000
Y46.5 Valproic acid	0.002	0.998	0.000
Y46.3 Deoxybarbiturates	0.002	0.998	0.000
Y46.1 Oxazolidinediones	0.002	0.998	0.000
Y46.0 Succinimides	0.002	0.998	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
M07.36 Other psoriatic arthropathies (Lower leg)	0.002	0.998	0.000
A04.7 Enterocolitis due to Clostridium difficile	0.000	0.998	0.002
H40.5 Glaucoma secondary to other eye disorders	0.000	0.998	0.002
M67.2 Synovial hypertrophy, not elsewhere classified	0.000	0.998	0.002
Y58 Bacterial vaccines	0.002	0.998	0.000
M25.56 Pain in joint (Lower leg)	0.002	0.998	0.000
G93.0 Cerebral cysts	0.002	0.998	0.000
K72.0 Acute and subacute hepatic failure	0.002	0.998	0.000
Y41.5 Antiviral drugs	0.002	0.998	0.000
Y48.4 Anaesthetic, unspecified	0.002	0.998	0.000
F32.8 Other depressive episodes	0.000	0.998	0.002
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.002	0.998	0.000
K10.8 Other specified diseases of jaws	0.000	0.998	0.002
Q55.6 Other congenital malformations of penis	0.002	0.998	0.000
C66 Malignant neoplasm of ureter	0.002	0.998	0.000
M81.98 Osteoporosis, unspecified (Other)	0.000	0.998	0.002
O75.7 Vaginal delivery following previous Caesarean section	0.000	0.998	0.002
Q61.3 Polycystic kidney, unspecified	0.000	0.998	0.002
Y46.6 Other and unspecified antiepileptics	0.002	0.998	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.002	0.998	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.002	0.998	0.000
N64.9 Disorder of breast, unspecified	0.000	0.998	0.002
Q60.2 Renal agenesis, unspecified	0.000	0.998	0.002
Y42.1 Thyroid hormones and substitutes	0.002	0.998	0.000
K77.8 Liver disorders in other diseases classified elsewhere	0.002	0.998	0.000
K77.0 Liver disorders in infectious and parasitic diseases classified elsewhere	0.002	0.998	0.000
Y59 Other and unspecified vaccines and biological substances	0.002	0.998	0.000
I42.1 Obstructive hypertrophic cardiomyopathy	0.002	0.998	0.000
K75.2 Nonspecific reactive hepatitis	0.002	0.998	0.000
K75.1 Phlebitis of portal vein	0.002	0.998	0.000
O00.1 Tubal pregnancy	0.000	0.998	0.002
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.002	0.998	0.000
O00 Ectopic pregnancy	0.000	0.998	0.002
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.002	0.998	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.002	0.998	0.000
H35.6 Retinal haemorrhage	0.000	0.998	0.002
Y49.0 Tricyclic and tetracyclic antidepressants	0.002	0.998	0.000
O07 Failed attempted abortion	0.000	0.998	0.002
O05 Other abortion	0.000	0.998	0.002
O01 Hydatidiform mole	0.000	0.998	0.002
M65.34 Trigger finger-Hand	0.002	0.998	0.000
O04.1 Incomplete, complicated by delayed or excessive haemorrhage	0.000	0.998	0.002
Y46.2 Hydantoin derivatives	0.002	0.998	0.000
F52.9 Unspecified sexual dysfunction, not caused by organic disorder or disease	0.002	0.998	0.000
F52.8 Other sexual dysfunction, not caused by organic disorder or disease	0.002	0.998	0.000
F52.7 Excessive sexual drive	0.002	0.998	0.000
F52.6 Nonorganic dyspareunia	0.002	0.998	0.000
F52.5 Nonorganic vaginismus	0.002	0.998	0.000
F52.4 Premature ejaculation	0.002	0.998	0.000
F52.3 Orgasmic dysfunction	0.002	0.998	0.000
F52.1 Sexual aversion and lack of sexual enjoyment	0.002	0.998	0.000
I98.2 Oesophageal varices in diseases classified elsewhere	0.002	0.998	0.000
K10.2 Inflammatory conditions of jaws	0.000	0.998	0.002
Q05.9 Spina bifida, unspecified	0.000	0.998	0.002
Q60.0 Renal agenesis, unilateral	0.000	0.998	0.002
Y48.5 Therapeutic gases	0.002	0.998	0.000
Y48.1 Parenteral anaesthetics	0.002	0.998	0.000
Y48.0 Inhaled anaesthetics	0.002	0.998	0.000
O08 Complications following abortion and ectopic and molar pregnancy	0.000	0.998	0.002
O06 Unspecified abortion	0.000	0.998	0.002
Q61 Cystic kidney disease	0.000	0.998	0.002
K71.9 Toxic liver disease, unspecified	0.001	0.998	0.000
K71.8 Toxic liver disease with other disorders of liver	0.001	0.998	0.000
K71.7 Toxic liver disease with fibrosis and cirrhosis of liver	0.001	0.998	0.000
K71.5 Toxic liver disease with chronic active hepatitis	0.001	0.998	0.000
K71.4 Toxic liver disease with chronic lobular hepatitis	0.001	0.998	0.000
K71.3 Toxic liver disease with chronic persistent hepatitis	0.001	0.998	0.000
K71.2 Toxic liver disease with acute hepatitis	0.001	0.998	0.000
K71.0 Toxic liver disease with cholestasis	0.001	0.998	0.000
N76.2 Acute vulvitis	0.000	0.998	0.002
K73 Chronic hepatitis, not elsewhere classified	0.002	0.998	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.002	0.998	0.000
O04.7 Complete or unspecified, complicated by embolism	0.000	0.998	0.002
O04.6 Complete or unspecified, complicated by delayed or excessive haemorrhage	0.000	0.998	0.002
O04.5 Complete or unspecified, complicated by genital tract and pelvic infection	0.000	0.998	0.002
O04.3 Incomplete, with other and unspecified complications	0.000	0.998	0.002
O04.2 Incomplete, complicated by embolism	0.000	0.998	0.002
O04.0 Incomplete, complicated by genital tract and pelvic infection	0.000	0.998	0.002
Y49.5 Other antipsychotics and neuroleptics	0.002	0.998	0.000
Y50.9 Central nervous system stimulant, unspecified	0.001	0.998	0.000
Y50.8 Other central nervous system stimulants	0.001	0.998	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.001	0.998	0.000
Y50.1 Opioid receptor antagonists	0.001	0.998	0.000
Y50.0 Analeptics	0.001	0.998	0.000
M07.38 Other psoriatic arthropathies (Other)	0.002	0.998	0.000
D86.9 Sarcoidosis, unspecified	0.002	0.998	0.000
K71.6 Toxic liver disease with hepatitis, not elsewhere classified	0.001	0.998	0.000
Q60 Renal agenesis and other reduction defects of kidney	0.000	0.998	0.002
H40-H42 Glaucoma	0.000	0.998	0.002
H36.0 Diabetic retinopathy	0.002	0.998	0.000
Q51.3 Bicornate uterus	0.002	0.998	0.000
Y49.9 Psychotropic drug, unspecified	0.001	0.998	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.001	0.998	0.000
Y49.7 Psychostimulants with abuse potential	0.001	0.998	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.001	0.998	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.001	0.998	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.001	0.998	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.001	0.998	0.000
Y58.9 Other and unspecified bacterial vaccines	0.001	0.998	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.001	0.998	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.001	0.998	0.000
Y58.5 Diphtheria vaccine	0.001	0.998	0.000
Y58.4 Tetanus vaccine	0.001	0.998	0.000
Y58.3 Plague vaccine	0.001	0.998	0.000
Y58.2 Cholera vaccine	0.001	0.998	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.001	0.998	0.000
F52.0 Lack or loss of sexual desire	0.001	0.998	0.000
K75.3 Granulomatous hepatitis, not elsewhere classified	0.001	0.998	0.000
F32.3 Severe depressive episode with psychotic symptoms	0.000	0.998	0.002
K71.1 Toxic liver disease with hepatic necrosis	0.001	0.998	0.000
M07.3 Other psoriatic arthropathies	0.002	0.998	0.000
O04.8 Complete or unspecified, with other and unspecified complications	0.000	0.998	0.001
Q61.9 Cystic kidney disease, unspecified	0.000	0.998	0.002
H53.1 Subjective visual disturbances	0.002	0.998	0.000
O90.8 Other complications of the puerperium, not elsewhere classified	0.000	0.998	0.002
Q61.5 Medullary cystic kidney	0.000	0.998	0.002
Q61.4 Renal dysplasia	0.000	0.998	0.001
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.001	0.998	0.000
Y42.4 Oral contraceptives	0.001	0.998	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.001	0.998	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.001	0.998	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.001	0.998	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.001	0.998	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.001	0.998	0.000
Y51.0 Anticholinesterase agents	0.001	0.998	0.000
Y53.4 Other laxatives	0.001	0.998	0.000
Y58.0 BCG vaccine	0.001	0.998	0.000
Y59.9 Vaccine or biological substance, unspecified	0.001	0.998	0.000
Y59.8 Other specified vaccines and biological substances	0.001	0.998	0.000
Y59.2 Protozoal vaccines	0.001	0.998	0.000
Y59.1 Rickettsial vaccines	0.001	0.998	0.000
Y59.0 Viral vaccines	0.001	0.998	0.000
Y40 Systemic antibiotics	0.002	0.998	0.000
M41.95 Scoliosis, unspecified (Thoracolumbar region)	0.000	0.998	0.002
K73.8 Other chronic hepatitis, not elsewhere classified	0.001	0.998	0.000
O00.8 Other ectopic pregnancy	0.000	0.998	0.001
O00.2 Ovarian pregnancy	0.000	0.998	0.001
O00.0 Abdominal pregnancy	0.000	0.998	0.001
Q64.3 Other atresia and stenosis of urethra and bladder neck	0.000	0.998	0.001
Y42.9 Other and unspecified hormone antagonists	0.001	0.998	0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.001	0.998	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.001	0.998	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.001	0.998	0.000
Y47.4 Bromine compounds	0.001	0.998	0.000
Y47.3 Paraldehyde	0.001	0.998	0.000
Y47.2 Chloral derivatives	0.001	0.998	0.000
Y47.0 Barbiturates, not elsewhere classified	0.001	0.998	0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.002	0.998	0.000
Y54.9 Mineral salts, not elsewhere classified	0.001	0.998	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.001	0.998	0.000
Y54.4 Loop [high-ceiling] diuretics	0.001	0.998	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.001	0.998	0.000
Y54.0 Mineralocorticoids	0.001	0.998	0.000
M07.30 Other psoriatic arthropathies (Multiple sites)	0.002	0.998	0.000
O01.9 Hydatidiform mole, unspecified	0.000	0.998	0.001
O01.1 Incomplete and partial hydatidiform mole	0.000	0.998	0.001
O01.0 Classical hydatidiform mole	0.000	0.998	0.001
O05.9 Complete or unspecified, without complication	0.000	0.998	0.001
O05.8 Complete or unspecified, with other and unspecified complications	0.000	0.998	0.001
O05.7 Complete or unspecified, complicated by embolism	0.000	0.998	0.001
O05.6 Complete or unspecified, complicated by delayed or excessive haemorrhage	0.000	0.998	0.001
O05.5 Complete or unspecified, complicated by genital tract and pelvic infection	0.000	0.998	0.001
O05.4 Incomplete, without complication	0.000	0.998	0.001
O05.3 Incomplete, with other and unspecified complications	0.000	0.998	0.001
O05.2 Incomplete, complicated by embolism	0.000	0.998	0.001
O05.1 Incomplete, complicated by delayed or excessive haemorrhage	0.000	0.998	0.001
O05.0 Incomplete, complicated by genital tract and pelvic infection	0.000	0.998	0.001
O07.9 Other and unspecified failed attempted abortion, without complication	0.000	0.998	0.001
O07.8 Other and unspecified failed attempted abortion, with other and unspecified complications	0.000	0.998	0.001
O07.7 Other and unspecified failed attempted abortion, complicated by embolism	0.000	0.998	0.001
O07.6 Other and unspecified failed attempted abortion, complicated by delayed or excessive haemorrhage	0.000	0.998	0.001
O07.5 Other and unspecified failed attempted abortion, complicated by genital tract and pelvic infection	0.000	0.998	0.001
O07.4 Failed medical abortion, without complication	0.000	0.998	0.001
O07.3 Failed medical abortion, with other and unspecified complications	0.000	0.998	0.001
O07.2 Failed medical abortion, complicated by embolism	0.000	0.998	0.001
O07.1 Failed medical abortion, complicated by delayed or excessive haemorrhage	0.000	0.998	0.001
O07.0 Failed medical abortion, complicated by genital tract and pelvic infection	0.000	0.998	0.001
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.998	0.002
G93.4 Encephalopathy, unspecified	0.002	0.998	0.000
T39.0 Salicylates	0.000	0.998	0.002
C44.6 Skin of upper limb, including shoulder	0.000	0.998	0.002
O06.8 Complete or unspecified, with other and unspecified complications	0.000	0.998	0.001
O06.7 Complete or unspecified, complicated by embolism	0.000	0.998	0.001
O06.6 Complete or unspecified, complicated by delayed or excessive haemorrhage	0.000	0.998	0.001
O06.5 Complete or unspecified, complicated by genital tract and pelvic infection	0.000	0.998	0.001
O06.4 Incomplete, without complication	0.000	0.998	0.001
O06.3 Incomplete, with other and unspecified complications	0.000	0.998	0.001
O06.2 Incomplete, complicated by embolism	0.000	0.998	0.001
O06.1 Incomplete, complicated by delayed or excessive haemorrhage	0.000	0.998	0.001
O06.0 Incomplete, complicated by genital tract and pelvic infection	0.000	0.998	0.001
O08.9 Complication following abortion and ectopic and molar pregnancy, unspecified	0.000	0.998	0.001
O08.8 Other complications following abortion and ectopic and molar pregnancy	0.000	0.998	0.001
O08.7 Other venous complications following abortion and ectopic and molar pregnancy	0.000	0.998	0.001
O08.6 Damage to pelvic organs and tissues following abortion and ectopic and molar pregnancy	0.000	0.998	0.001
O08.5 Metabolic disorders following abortion and ectopic and molar pregnancy	0.000	0.998	0.001
O08.4 Renal failure following abortion and ectopic and molar pregnancy	0.000	0.998	0.001
O08.3 Shock following abortion and ectopic and molar pregnancy	0.000	0.998	0.001
O08.2 Embolism following abortion and ectopic and molar pregnancy	0.000	0.998	0.001
O08.0 Genital tract and pelvic infection following abortion and ectopic and molar pregnancy	0.000	0.998	0.001
Q61.8 Other cystic kidney diseases	0.000	0.998	0.001
Q61.1 Polycystic kidney, infantile type	0.000	0.998	0.001
Y42.2 Antithyroid drugs	0.001	0.998	0.000
Y54.8 Agents affecting uric acid metabolism	0.001	0.998	0.000
M07.31 Other psoriatic arthropathies (Shoulder region)	0.001	0.998	0.000
K73.1 Chronic lobular hepatitis, not elsewhere classified	0.001	0.998	0.000
K73.0 Chronic persistent hepatitis, not elsewhere classified	0.001	0.998	0.000
R44.0 Auditory hallucinations	0.000	0.998	0.001
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.001	0.998	0.000
C80.9 Malignant neoplasm, unspecified	0.001	0.998	0.000
N42.8 Other specified disorders of prostate	0.000	0.998	0.002
O06.9 Complete or unspecified, without complication	0.000	0.998	0.001
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.001	0.998	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.001	0.998	0.000
Y53.7 Emetics	0.001	0.998	0.000
Y53.6 Antidiarrhoeal drugs	0.001	0.998	0.000
Y53.5 Digestants	0.001	0.998	0.000
Y53.3 Saline and osmotic laxatives	0.001	0.998	0.000
Y53.2 Stimulant laxatives	0.001	0.998	0.000
Y53.0 Histamine H2-receptor antagonists	0.001	0.998	0.000
Y84.6 Urinary catheterisation	0.000	0.998	0.001
K22.9 Disease of oesophagus, unspecified	0.000	0.999	0.001
M81.9 Osteoporosis, unspecified	0.000	0.999	0.001
Q60.6 Potter's syndrome	0.000	0.999	0.001
Q60.5 Renal hypoplasia, unspecified	0.000	0.999	0.001
Q60.4 Renal hypoplasia, bilateral	0.000	0.999	0.001
Q60.3 Renal hypoplasia, unilateral	0.000	0.999	0.001
Q60.1 Renal agenesis, bilateral	0.000	0.999	0.001
Y40.9 Systemic antibiotic, unspecified	0.001	0.999	0.000
H42 Glaucoma in diseases classified elsewhere	0.000	0.999	0.001
M81.97 Osteoporosis, unspecified (Ankle and foot)	0.000	0.999	0.001
O08.1 Delayed or excessive haemorrhage following abortion and ectopic and molar pregnancy	0.000	0.999	0.001
M07.39 Other psoriatic arthropathies (Site unspecified)	0.001	0.999	0.000
M07.35 Other psoriatic arthropathies (Pelvic region and thigh)	0.001	0.999	0.000
M07.33 Other psoriatic arthropathies (Forearm)	0.001	0.999	0.000
M07.32 Other psoriatic arthropathies (Upper arm)	0.001	0.999	0.000
M79.28 Neuralgia and neuritis, unspecified (Other)	0.000	0.999	0.001
C77.1 Intrathoracic lymph nodes	0.001	0.999	0.000
K86.0 Alcohol-induced chronic pancreatitis	0.000	0.999	0.001
Y40.0 Penicillins	0.001	0.999	0.000
Y43.1 Antineoplastic antimetabolites	0.001	0.999	0.000
I05.0 Mitral stenosis	0.000	0.999	0.001
Y40.6 Rifamycins	0.001	0.999	0.000
Y40.2 Chloramphenicol group	0.001	0.999	0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.001	0.999	0.000
Y49.2 Other and unspecified antidepressants	0.001	0.999	0.000
M07.37 Other psoriatic arthropathies (Ankle and foot)	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations